Dr. Elmaleh is a veteran scientist, inventor, and entrepreneur who also serves as Associate Professor at Harvard Medical School and Director of Contrast Media Chemistry at Massachusetts General Hospital. His work has led to approved treatments representing over a billion dollars in shareholder value. He was named by Genetic Engineering & Biotechnology News to the 2014 list of “Biotech’s Most Enterprising Entrepreneurs” Prior to founding and serving as a Chairman of LizAI Inc., Dr. Elmaleh founded and led multiple diagnostic and pharmaceutical biotech companies, naming Molecular Insight (formerly Biostream), Mersana (formerly NanoPharma), Puretech Health, AZTherapies, Xylex, Atroo and recently CyberAra, a cybersecurity company.

Dr. Nguyen is a scientist and innovator in multiple areas, with 15-year experience in software development in both academic and industrial settings. His Ph.D. work especially focuses on the development of cutting-edge AI, security & privacy technologies. Nguyen has worked in a wide range of important privacy design areas, including but not limited to, Engineering, Legal, Policy, and Developer Relation. He has successfully led teams building core software components that help improve the security & performance at the enterprise level.

Dr. Eran Segal is a Professor at the Department of Computer Science and Applied Mathematics at the Weizmann Institute of Science. Dr. Segal’s Computational and Systems Biology research focuses on Nutrition, Genetics, Microbiome, and Gene Regulation and their effect on human health and disease. He has in-depth expertise in personalized medicine using machine learning, computational biology, probabilistic modeling, and heterogeneous genomic and clinical data analysis. Dr. Segal has received several awards and honors for his work, to highlight the Michael Bruno Award and the Overton Prize, awarded annually by the International Society for Bioinformatics (ICSB) to one scientist for outstanding accomplishments in the field of computational biology. Dr. Segal is also a veteran entrepreneur who founded DayTwo.

Dr. Ziv Neeman is an expert in Interventional Radiology and Diagnostic Imaging. He is currently the Director at the Diagnostic Imaging and Nuclear Medicine Institute, Emek Medical Center, and the Chair of the Diagnostic Imaging Forum, School of Medicine Ruth and Bruce Rapport, Technion, Israel. Before joining LizAI, Dr. Neeman advised multiple successful biotech and AI-based startups.

Dr. Ho got his Ph.D. degree in Pharmacy. He is a scientist, innovator, and entrepreneur in multidisciplinary areas, with more than 15-year experience and in-depth expertise in pharmaceuticals and medicines. He has more than 25 publications and 6 patents pending and issued on pharmaceuticals and technologies. He has experience in leading a biotech startup to successful fund-raising.